Significance of different molecular forms of serum PSA : The free, noncomplexed form of PSA versus that complexed to α1-antichymotrypsin
(1993) In Urologic Clinics of North America 20(4). p.681-686- Abstract
Prostate specific antigen is an abundant prostate-derived serine protease in the seminal fluid. Low concentrations of the protein are normally released into blood, but above normal concentrations are frequently detected in prostate disease. The PSA-ACT complex is the predominant molecular form of serum PSA (up to ≃95%) although complex formation is slow between the purified proteins in vitro. A free, noncomplexed form of PSA constitutes a minor fraction of the serum PSA, although serum ACT occurs in large molar excess. The free, noncomplexed form of serum PSA is reported to constitute a significantly smaller proportion of the PSA in untreated prostate cancer than in BPH. The molecular basis for this finding is unclear, but measurements... (More)
Prostate specific antigen is an abundant prostate-derived serine protease in the seminal fluid. Low concentrations of the protein are normally released into blood, but above normal concentrations are frequently detected in prostate disease. The PSA-ACT complex is the predominant molecular form of serum PSA (up to ≃95%) although complex formation is slow between the purified proteins in vitro. A free, noncomplexed form of PSA constitutes a minor fraction of the serum PSA, although serum ACT occurs in large molar excess. The free, noncomplexed form of serum PSA is reported to constitute a significantly smaller proportion of the PSA in untreated prostate cancer than in BPH. The molecular basis for this finding is unclear, but measurements of the proportion of the free form of serum PSA or the proportion of serum PSA- ACT may facilitate discrimination between prostate cancer and BPH.
(Less)
- author
- Lilja, H. LU
- organization
- publishing date
- 1993
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Urologic Clinics of North America
- volume
- 20
- issue
- 4
- pages
- 6 pages
- publisher
- W.B. Saunders
- external identifiers
-
- pmid:7505976
- scopus:0027889117
- ISSN
- 0094-0143
- DOI
- 10.1016/S0094-0143(21)00920-4
- language
- English
- LU publication?
- yes
- id
- 2e72c0ec-282a-49f2-815a-b1e792b35c07
- date added to LUP
- 2022-12-08 13:11:32
- date last changed
- 2024-01-02 13:55:50
@article{2e72c0ec-282a-49f2-815a-b1e792b35c07, abstract = {{<p>Prostate specific antigen is an abundant prostate-derived serine protease in the seminal fluid. Low concentrations of the protein are normally released into blood, but above normal concentrations are frequently detected in prostate disease. The PSA-ACT complex is the predominant molecular form of serum PSA (up to ≃95%) although complex formation is slow between the purified proteins in vitro. A free, noncomplexed form of PSA constitutes a minor fraction of the serum PSA, although serum ACT occurs in large molar excess. The free, noncomplexed form of serum PSA is reported to constitute a significantly smaller proportion of the PSA in untreated prostate cancer than in BPH. The molecular basis for this finding is unclear, but measurements of the proportion of the free form of serum PSA or the proportion of serum PSA- ACT may facilitate discrimination between prostate cancer and BPH.</p>}}, author = {{Lilja, H.}}, issn = {{0094-0143}}, language = {{eng}}, number = {{4}}, pages = {{681--686}}, publisher = {{W.B. Saunders}}, series = {{Urologic Clinics of North America}}, title = {{Significance of different molecular forms of serum PSA : The free, noncomplexed form of PSA versus that complexed to α1-antichymotrypsin}}, url = {{http://dx.doi.org/10.1016/S0094-0143(21)00920-4}}, doi = {{10.1016/S0094-0143(21)00920-4}}, volume = {{20}}, year = {{1993}}, }